The global tuberculosis burden remains substantial, with more than 10 million people newly
ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade …

Background and aim Coronavirus disease 2019 (COVID-19) coinfection with other
respiratory pathogens poses a serious concern that can complicate diagnosis, treatment …

The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and
service delivery in 2020, setting back progress in the fight against TB by several years. As …

Young adults had been widely perceived as a low-risk group for COVID-19 severity;
therefore, they were deprioritised within the mass vaccination strategies as their prognosis of …

Abstract Background In Portugal, Outpatient Tuberculosis Centres (OTBC) are responsible
for the diagnosis, treatment, screening and prevention of tuberculosis (TB), and only severe …

Background: We aimed to visualize and classify the time series of COVID-19, tuberculosis
(TB) notification, and TB outcomes (cure, treatment abandonment, and death), verify the …

Background The COVID-19 pandemic disrupted TB services worldwide, leading to
diagnostic delays. There have been few published reports describing how the pandemic …

Despite being a preventable and curable disease, tuberculosis (TB) is still a major global
health threat and the second leading cause of death due to an infectious agent worldwide …

Background The proportion of tuberculosis (TB) patients who are older adults is increasing
worldwide. Nearly 60% of TB patients in Japan are 70 years or older, and the TB incidence …

Evaluating cross-country variability on the impact of the COVID-19 pandemic on tuberculosis
(TB) may provide urgent inputs to control programs as countries recover from the pandemic …